Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

500 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic Factors for Postrelapse Survival after ex Vivo CD34+-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma.
Gomez-Arteaga A, Shah GL, Baser RE, Scordo M, Ruiz JD, Bryant A, Dahi PB, Ghosh A, Lahoud OB, Landau HJ, Landgren O, Shaffer BC, Smith EL, Koehne G, Perales MA, Giralt SA, Chung DJ. Gomez-Arteaga A, et al. Among authors: landgren o. Biol Blood Marrow Transplant. 2020 Nov;26(11):2040-2046. doi: 10.1016/j.bbmt.2020.07.016. Epub 2020 Jul 23. Biol Blood Marrow Transplant. 2020. PMID: 32712326 Free PMC article.
Solid cancers after allogeneic hematopoietic cell transplantation.
Rizzo JD, Curtis RE, Socié G, Sobocinski KA, Gilbert E, Landgren O, Travis LB, Travis WD, Flowers ME, Friedman DL, Horowitz MM, Wingard JR, Deeg HJ. Rizzo JD, et al. Among authors: landgren o. Blood. 2009 Jan 29;113(5):1175-83. doi: 10.1182/blood-2008-05-158782. Epub 2008 Oct 29. Blood. 2009. PMID: 18971419 Free PMC article.
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study.
Kumar SK, Lee JH, Lahuerta JJ, Morgan G, Richardson PG, Crowley J, Haessler J, Feather J, Hoering A, Moreau P, LeLeu X, Hulin C, Klein SK, Sonneveld P, Siegel D, Bladé J, Goldschmidt H, Jagannath S, Miguel JS, Orlowski R, Palumbo A, Sezer O, Rajkumar SV, Durie BG; International Myeloma Working Group. Kumar SK, et al. Leukemia. 2012 Jan;26(1):149-57. doi: 10.1038/leu.2011.196. Epub 2011 Jul 29. Leukemia. 2012. PMID: 21799510 Free PMC article.
Treating myeloma: the future is already here!
Landgren O, Korde N. Landgren O, et al. Blood. 2012 Aug 30;120(9):1754-6. doi: 10.1182/blood-2012-06-434571. Blood. 2012. PMID: 22936733 Free article. No abstract available.
IMWG consensus on risk stratification in multiple myeloma.
Chng WJ, Dispenzieri A, Chim CS, Fonseca R, Goldschmidt H, Lentzsch S, Munshi N, Palumbo A, Miguel JS, Sonneveld P, Cavo M, Usmani S, Durie BG, Avet-Loiseau H; International Myeloma Working Group. Chng WJ, et al. Leukemia. 2014 Feb;28(2):269-77. doi: 10.1038/leu.2013.247. Epub 2013 Aug 26. Leukemia. 2014. PMID: 23974982 Review.
Serum immunoglobulin free light chains and post-transplant lymphoproliferative disorder among allogeneic hematopoietic stem cell transplant recipients.
Engels EA, Landgren O, Costello R, Burton D, Mailankody S, Storek J. Engels EA, et al. Among authors: landgren o. Bone Marrow Transplant. 2015 Jan;50(1):146-7. doi: 10.1038/bmt.2014.213. Epub 2014 Sep 29. Bone Marrow Transplant. 2015. PMID: 25265459 Free PMC article. Clinical Trial. No abstract available.
500 results